CliffBio
small molecule

LEVOFLOXACIN

LEVOFLOXACIN

Loss of exclusivity—loss of exclusivity
CompanyNovitium Pharma →See this company's full patent-cliff portfolio

Drug detail

Brand nameLEVOFLOXACIN
Active ingredientLEVOFLOXACIN
Strength250MG/10ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalJune 2011
Marketing statusRX

More from Novitium Pharma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.